Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 22.77% is 36% above its 5-year average of 16.74%, near the high end of its 5-year range (-16.97%–27.77%).
1.34% below its 12-month average of 23.08%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 20.57%.
OPERATING MARGIN
22.77%
OPERATING MARGIN AVG TTM
23.08%
OPERATING MARGIN AVG 3Y
20.48%
OPERATING MARGIN AVG 5Y
16.74%
OPERATING MARGIN AVG 10Y
16.83%
OPERATING MARGIN AVG 15Y
17.92%
OPERATING MARGIN AVG 20Y
21.93%
CURRENT VS TTM AVG
-1.34%
CURRENT VS 3Y AVG
+11.19%
CURRENT VS 5Y AVG
+36.05%
CURRENT VS 10Y AVG
+35.30%
CURRENT VS 15Y AVG
+27.05%
CURRENT VS 20Y AVG
+3.83%
SECTOR MEDIAN · HEALTHCARE
14.90%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+52.82%
vs the sector median at left
AstraZeneca PLC
Market Cap
$252.62B
Operating Margin
22.77%
TTM Avg
23.08%
3Y Avg
20.48%
5Y Avg
16.74%
Market Cap
$240.97B
Operating Margin
17.69%
TTM Avg
18.04%
3Y Avg
18.11%
5Y Avg
20.54%
Market Cap
$185.26B
Operating Margin
43.10%
TTM Avg
42.74%
3Y Avg
42.98%
5Y Avg
42.70%
Market Cap
$183.36B
Operating Margin
39.74%
TTM Avg
22.76%
3Y Avg
25.11%
5Y Avg
25.54%
Market Cap
$177.12B
Operating Margin
17.03%
TTM Avg
17.21%
3Y Avg
17.41%
5Y Avg
17.71%
Market Cap
$340.79B
Operating Margin
4.82%
TTM Avg
6.16%
3Y Avg
7.45%
5Y Avg
7.80%
Market Cap
$351.56B
Operating Margin
29.16%
TTM Avg
25.33%
3Y Avg
25.67%
5Y Avg
27.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AstraZeneca PLC (AZN) | $252.62B | 22.77% | 23.08% | 20.48% | 16.74% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $240.97B | 17.69% | 18.04% | 18.11% | 20.54% |
| Amgen Inc. (AMGN)vs › | $203.12B | 33.18% | 25.38% | 28.78% | 30.08% |
| Novo Nordisk A/S (NVO)vs › | $185.26B | 43.10% | 42.74% | 42.98% | 42.70% |
| Gilead Sciences, Inc. (GILD)vs › | $183.36B | 39.74% | 22.76% | 25.11% | 25.54% |
| Abbott Laboratories (ABT)vs › | $177.12B | 17.03% | 17.21% | 17.41% | 17.71% |
| UnitedHealth Group Incorporated (UNH)vs › | $340.79B | 4.82% | 6.16% | 7.45% | 7.80% |
| Pfizer Inc. (PFE)vs › | $156.51B | 25.08% | 25.29% | 24.23% | 24.05% |
| Roche Holding AG (RHHBY)vs › | $351.56B | 29.16% | 25.33% | 25.67% | 27.00% |
| Merck & Co., Inc. (MRK)vs › | $358.00B | 36.17% | 33.84% | 25.86% | 23.98% |
Gross Margin
81.9%
Operating Margin
22.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 20.57% |
| 2026-03-31 | 27.77% |
| 2025-12-31 | 19.21% |
| 2025-09-30 | 23.59% |
| 2025-06-30 | 24.27% |
| 2025-03-30 | 27.04% |
| 2024-12-31 | 13.67% |
| 2024-09-30 | 15.53% |
| 2024-06-30 | 21.22% |
| 2024-03-31 | 24.57% |
| 2023-12-31 | 10.26% |
| 2023-09-30 | 17.00% |
| 2023-06-30 | 21.51% |
| 2023-03-31 | 23.43% |
| 2022-12-31 | 9.76% |
| 2022-09-30 | 11.34% |
| 2022-06-30 | 5.00% |
| 2022-03-31 | 7.71% |
| 2021-12-31 | -2.43% |
| 2021-09-30 | -16.97% |
| 2021-06-30 | 13.71% |
| 2021-03-31 | 25.89% |
| 2020-12-31 | 20.07% |
| 2020-09-30 | 17.80% |
| 2020-06-30 | 20.46% |
| 2020-03-31 | 19.20% |
| 2019-12-31 | 8.66% |
| 2019-09-30 | 11.82% |
| 2019-06-30 | 8.47% |
| 2019-03-31 | 19.98% |
| 2018-12-31 | 16.78% |
| 2018-09-30 | 15.94% |
| 2018-06-30 | 14.80% |
| 2018-03-31 | 13.44% |
| 2017-12-31 | 11.87% |
| 2017-09-30 | 18.44% |
| 2017-06-30 | 18.31% |
| 2017-03-31 | 16.97% |
| 2016-12-31 | 45.35% |
| 2016-09-30 | 18.04% |
| 2016-06-30 | 5.41% |
| 2016-03-31 | 16.97% |
| 2015-12-31 | 17.00% |
| 2015-09-30 | 19.68% |
| 2015-06-30 | 14.63% |
| 2015-03-31 | 15.40% |
| 2014-12-31 | -5.22% |
| 2014-09-30 | 8.19% |
| 2014-06-30 | 16.40% |
| 2014-03-31 | 12.94% |
| 2013-12-31 | -8.64% |
| 2013-09-30 | 27.30% |
| 2013-06-30 | 19.26% |
| 2013-03-31 | 21.88% |
| 2012-12-31 | 26.97% |
| 2012-09-30 | 32.27% |
| 2012-06-30 | 28.05% |
| 2012-03-31 | 29.39% |
| 2011-12-31 | 25.03% |
| 2011-09-30 | 51.89% |
| 2011-06-30 | 35.17% |
| 2011-03-31 | 41.02% |
| 2010-12-31 | 27.98% |
| 2010-09-30 | 30.46% |
| 2010-06-30 | 37.10% |
| 2010-03-31 | 42.48% |
| 2009-12-31 | 25.99% |
| 2009-09-30 | 39.07% |
| 2009-06-30 | 35.83% |
| 2009-03-31 | 41.07% |
| 2008-12-31 | 23.09% |
| 2008-09-30 | 32.44% |
| 2008-06-30 | 31.08% |
| 2008-03-31 | 29.40% |
| 2007-12-31 | 23.61% |
| 2007-09-30 | 28.28% |
| 2007-06-30 | 27.13% |
| 2007-03-31 | 31.15% |
| 2006-12-31 | 28.00% |
| 2006-09-30 | 32.32% |
| 2006-06-30 | 32.17% |
| 2006-03-31 | 31.97% |
| 2005-12-31 | 26.03% |
| 2005-09-30 | 29.28% |
| 2005-06-30 | 28.02% |
| 2005-03-31 | 25.30% |
| 2004-12-31 | -51.06% |
| 2004-09-30 | 22.26% |
| 2004-06-30 | 19.89% |
| 2004-03-31 | 20.73% |
| 2003-12-31 | 17.42% |
| 2003-09-30 | 22.92% |
| 2003-06-30 | 20.05% |
| 2003-03-31 | 26.86% |
| 2002-12-31 | 15.50% |
| 2002-09-30 | 21.08% |
